Marc J. Yoskowitz
Director · Keenova Therapeutics plc
Individual
- 2025
- Jul 18, 2026
- 6
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Marc J. Yoskowitz's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Herriot Tabuteau - $97.80M in AXSM purchases and sales in the last 12 months
- TCO GROUP HOLDINGS, L.P. - $92.50M in INNV purchases and sales in the last 12 months
- IGNITE AGGREGATOR LP - $92.50M in INNV purchases and sales in the last 12 months
- SUVRETTA CAPITAL MANAGEMENT, LLC - $90.98M in MANE purchases and sales in the last 12 months
- Steven Leonard Chapman - $89.87M in NTRA purchases and sales in the last 12 months
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Marc J. Yoskowitz?
Marc J. Yoskowitz is a corporate insider, tracked as Director of Mereo BioPharma Group plc (MREO). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Marc J. Yoskowitz last file a Form 4?
The most recent primary Form 4 on record is dated 18 July 2026, one of 6 filings going back to 2025.